Can a simple blood test decide when heart failure patients go home?
NCT ID NCT03103932
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether using a blood test called NTproBNP can help doctors decide the best time to discharge patients hospitalized with worsening heart failure. 750 participants will be randomly assigned to either a biomarker-guided discharge plan or usual care. The goal is to see if this approach reduces hospital readmissions and keeps patients healthier longer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Biomarker guided discharge algorithm
What this could lead to
If successful, this could lead to a more personalized discharge plan for heart failure patients, potentially reducing hospital readmissions and improving recovery.
What could go wrong
This is an early-stage study testing a new decision-making tool, not a treatment. The biomarker approach may not improve outcomes compared to standard care, and results may not apply to all heart failure patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Ottawa Heart Institute
RECRUITINGOttawa, Ontario, K1Y 4W7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••